查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423400

2024-2032 年按产品、应用、最终用户和地区分類的白蛋白市场报告

Albumin Market Report by Product, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2023年全球白蛋白市场规模达61亿美元。展望未来， IMARC Group预计到2032年市场规模将达到98亿美元，2024-2032年复合年增长率（CAGR）为5.4%。治疗低血容的手术中广泛采用产品、改善医疗基础设施（尤其是在发展中地区）以及私人和公共投资涌入医疗保健是推动市场的一些主要因素。

白蛋白是主要由肝臟产生的蛋白质，在多种生理功能中发挥至关重要的作用。它是人体血浆中最丰富的蛋白质，透过维持渗透压来调节血液量。白蛋白也作为荷尔蒙、脂肪酸和药物等物质的载体分子，帮助它们在体内运输。白蛋白的一个关键功能是帮助防止液体从血管中渗漏，从而确保必需的液体保留在循环系统内。血液中白蛋白的异常水平可以表示各种健康状况。低水平可能表示肝臟或肾臟疾病、营养不良或慢性疾病，而水平升高通常不太常见，可能表示脱水或严重感染。因此，白蛋白水平的测量通常包含在血液测试中，作为常规医学评估的一部分。

外科手术数量的增加主要推动了全球市场。白蛋白通常在手术中用于治疗低血容积，即血浆容量减少的情况。随着全球人口持续老化以及手术技术的不断进步，进行的手术数量不断增加。这一趋势与白蛋白需求的上升直接相关，从而推动市场成长。促进市场成长的另一个重要因素是白蛋白产业向新兴市场的扩张。发展中国家提供了一个尚未开发的市场，医疗保健支出不断增加，医疗保健基础设施不断改善。随着这些国家医疗保健系统的进步，对包括白蛋白在内的高品质医疗用品的需求不断增加。此外，人们越来越意识到早期诊断和治疗需要白蛋白的疾病的重要性，这是推动市场的另一个因素。此外，私人和公共投资的涌入医疗保健领域正在创造积极的市场前景。

白蛋白市场趋势/驱动因素：

慢性病发生率上升

白蛋白产业最重要的市场驱动因素之一是肝硬化、肾臟疾病和糖尿病等慢性疾病发生率的上升。这些情况通常会导致白蛋白水平异常，需要定期监测并可能进行补充。此外，这些慢性病的盛行率不断上升与人口老化、不良饮食习惯以及缺乏运动和高压力等生活方式因素有关。同时，不断增长的患者群体需要增加用于诊断和治疗目的的白蛋白产品的供应。治疗这些疾病对白蛋白的需求不断增加，从而推动了该行业的成长。医院和诊所正在加强对基于白蛋白的测试和治疗的依赖，从而增加需求并推动市场成长。

生物技术和药物研究进展

生物技术和药物研究的技术进步也被证明是白蛋白产业的主要动力。这些进步促进了大规模分离、纯化和生产白蛋白的方法的改进，使其更容易获得且更具成本效益。此外，重组 DNA 技术的创新技术为白蛋白应用开闢了新途径，包括将其用作标靶治疗的药物递送剂。此外，研究进展为白蛋白在伤口癒合和组织再生等新应用的使用铺平了道路。对研发活动的持续投资显示白蛋白产业前景光明，有助于其扩张。

监管支持和批准

政府法规和指南在推动白蛋白市场方面发挥着至关重要的作用。监管机构为白蛋白产品的安全生产、品质控制和分销提供指南。同时，此类标准化的存在不仅可以建立消费者的信任，还可以鼓励製药公司投资高品质的产品。及时批准新的基于白蛋白的产品或疗法可以大大加速市场渗透，从而成为该行业的驱动力。此外，这些指南的全球统一确保了供应链的精简和高效，从而促进新的和创新的白蛋白产品更快地上市。

本报告回答的关键问题

  • 2023年全球白蛋白市场规模？
  • 2024-2032年全球白蛋白市场的预期成长率是多少？
  • 推动全球白蛋白市场的关键因素是什么？
  • COVID-19 对全球白蛋白市场有何影响？
  • 基于该产品的全球白蛋白市场的细分情况如何？
  • 根据应用，全球白蛋白市场的细分情况如何？
  • 基于最终用户的全球白蛋白市场的细分情况如何？
  • 全球白蛋白市场的重点区域有哪些？
  • 全球白蛋白市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球白蛋白市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 人血清白蛋白
    • 市场走向
    • 市场预测
  • 牛血清白蛋白
    • 市场走向
    • 市场预测
  • 重组白蛋白
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 疗法
    • 市场走向
    • 市场预测
  • 药物製剂和疫苗
    • 市场走向
    • 市场预测
  • 媒体的组成部分
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Albumedix Ltd
    • Biotest AG
    • Celgene Corporation (Bristol-Myers Squibb Company)
    • CSL Limited
    • Grifols SA
    • HiMedia Laboratories
    • Medxbio Pte Ltd
    • Merck KGaA
    • Octapharma AG
    • Takeda Pharmaceutical Company Limited
    • Thermo Fisher Scientific Inc.
    • Ventria Bioscience Inc.
Product Code: SR112024A4493

Abstract

The global albumin market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The widespread product adoption in the operations to treat hypovolemia, the improving healthcare infrastructure, especially across developing regions, and the influx of both private and public investment in healthcare are some of the major factors propelling the market.

Albumin is a protein produced primarily by the liver and plays a vital role in various physiological functions. It is the most abundant protein in human blood plasma and serves to regulate blood volume by maintaining the osmotic pressure. Albumin also acts as a carrier molecule for substances such as hormones, fatty acids, and medications, aiding in their transport throughout the body. A key function of albumin is to help prevent fluid leakage from blood vessels, thus ensuring that essential fluids remain within the circulatory system. Abnormal levels of albumin in the blood can be indicative of various health conditions. Low levels may point to liver or kidney disorders, malnutrition, or chronic illness, while elevated levels are generally less common and could be indicative of dehydration or severe infection. Hence, the measurement of albumin levels is often included in blood tests as part of routine medical assessments.

The increasing number of surgical procedures majorly drives the global market. Albumin is commonly used in operations to treat hypovolemia, a condition where there is a decrease in the volume of blood plasma. As the global population continues to age and as surgical techniques continue to advance, the number of surgeries being performed is increasing. This trend directly correlates with an uptick in the demand for albumin, thereby driving market growth. Another significant factor contributing to market growth is the expansion of the albumin industry into emerging markets. Developing countries present an untapped market with increasing healthcare spending and improving healthcare infrastructure. As healthcare systems in these countries advance, the demand for high-quality medical supplies, including albumin, rises. In addition, the accelerating awareness about the importance of early diagnosis and treatment of conditions that require albumin is another factor driving the market. Moreover, the influx of both private and public investment in healthcare is creating a positive market outlook.

Albumin Market Trends/Drivers:

Rising Incidence of Chronic Diseases

One of the most significant market drivers for the albumin industry is the rising incidence of chronic diseases such as liver cirrhosis, kidney disorders, and diabetes. These conditions often result in abnormal albumin levels, necessitating regular monitoring and possible supplementation. In addition, the escalating prevalence of these chronic diseases is linked to an aging population, poor dietary habits, and lifestyle factors like lack of exercise and high stress levels. In confluence with this, the growing patient pool demands an increasing supply of albumin products for both diagnostic and therapeutic purposes. The escalating need for albumin in treating these diseases is thereby propelling growth in the industry. Hospitals and clinics are intensifying their reliance on albumin-based tests and treatments, thereby increasing demand and driving market growth.

Advances in Biotechnology and Pharmaceutical Research

Technological advancements in biotechnology and pharmaceutical research have also proven to be a major driver for the albumin industry. These advances have facilitated improved methods of isolating, purifying, and producing albumin on a large scale, thereby making it more accessible and cost-effective. Additionally, innovative techniques in recombinant DNA technology have opened new avenues for albumin applications, including its use as a drug delivery agent for targeted therapies. Additionally, progress in research has paved the way for albumin's use in novel applications such as wound healing and tissue regeneration. The ongoing investments in research and development activities indicate a promising trajectory for the albumin industry, contributing to its expansion.

Regulatory Support and Approvals

Governmental regulations and guidelines play a crucial role in driving the albumin market. Regulatory bodies provide guidelines for the safe production, quality control, and distribution of albumin products. In confluence with this, the presence of such standardizations not only builds consumer trust but also encourages pharmaceutical companies to invest in high-quality products. Timely approvals for new albumin-based products or therapies can substantially accelerate market penetration, thereby acting as a driver for the industry. Moreover, the global harmonization of these guidelines ensures a streamlined and efficient supply chain, facilitating faster time-to-market for new and innovative albumin-based products.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global albumin market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Human Serum Albumin

Bovine Serum Albumin

Recombinant Albumin

Human serum albumin dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes human serum albumin, bovine serum albumin, and recombinant albumin. According to the report, human serum albumin represented the largest segment.

The market for human serum albumin products within the albumin industry is experiencing robust growth, propelled by multiple market drivers. A key influencer is the escalating prevalence of chronic liver and kidney diseases that necessitate regular monitoring and treatment of albumin levels. The rising number of surgical procedures, where human serum albumin is used to manage fluid balance, further fuels demand. Advances in biotechnological methods have made it easier to produce and purify human serum albumin, thereby making the product more cost-effective and accessible. This has led to its increased utilization in a range of medical and non-medical applications, such as drug formulation and vaccine stabilization. Additionally, the industry benefits from the regulatory support of agencies like the FDA and EMA, which ensures the quality and safety of these products, building consumer trust. Investment in healthcare from both public and private sectors also aids in market expansion, supporting research and development activities for innovative applications of human serum albumin. These factors collectively serve to drive the market for human serum albumin products.

Breakup by Application:

Therapeutics

Drug Formulation and Vaccine

Component of Media

Others

Therapeutics holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. These include therapeutics, drug formulation and vaccine, component of media, and others. According to the report, therapeutics accounted for the largest market share.

The therapeutics application segment in the albumin industry is witnessing significant growth, driven by multiple converging factors. Foremost among these is the increasing prevalence of chronic conditions like liver disease, kidney disorders, and diabetes, which necessitate the use of albumin-based treatments to regulate blood volume and protein levels. The rising number of surgical procedures, especially in an aging global population, also contributes to elevated demand for albumin as it is commonly used to manage fluid balance during surgeries. Advances in biotechnological research have led to the development of specialized albumin formulations optimized for drug delivery systems, thereby expanding its therapeutic applications. Regulatory bodies like the FDA and EMA have facilitated market growth by setting stringent quality control measures, thereby ensuring the efficacy and safety of albumin products used in therapeutics. Investments from private and public sectors in healthcare infrastructure and research also provide a conducive environment for the expansion of albumin's therapeutic applications. These driving factors combine to propel the market growth of the therapeutics application in the albumin industry.

Breakup by End User:

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Research Institutes

Hospitals and clinics dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes. According to the report, hospitals and clinics represented the largest segment.

The hospital and clinics segment is a major end-user in the albumin industry, and its market growth is fueled by several influential drivers. First and foremost, the rise in the incidence of chronic diseases like liver and kidney disorders requires consistent monitoring and treatment, often involving albumin-based products. This creates a steady demand for albumin in hospital settings for both diagnostic and therapeutic applications. Furthermore, the increasing number of surgical procedures that utilize albumin for fluid management further escalates demand within hospitals and clinics. Advances in healthcare infrastructure, supported by both public and private investment, have led to an uptick in the adoption of albumin products, as these settings aim for better patient outcomes and quality of care. Regulatory support, in the form of guidelines from bodies like the FDA and EMA, assures the quality of albumin products, thereby building trust and facilitating their usage in hospital settings. Collectively, these factors make hospitals and clinics a pivotal end-user segment, driving demand and, consequently, market growth for the albumin industry.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest albumin market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America exhibited the largest segment.

The albumin industry in North America is experiencing significant growth, driven by a variety of factors that create a strong demand for albumin products. One major driver is the high prevalence of chronic conditions like liver diseases, kidney disorders, and diabetes in the region, necessitating frequent monitoring and intervention involving albumin. Additionally, North America has a well-developed healthcare infrastructure with a substantial number of surgical procedures taking place annually, thereby increasing the usage of albumin for surgical and critical care. Technological advancements in biopharmaceuticals, supported by considerable R&D investment, have also contributed to diversifying albumin applications, further driving the market. Regulatory support from agencies such as the FDA assures product quality and safety, enhancing consumer trust. Furthermore, public and private investments in healthcare have been strong, resulting in more hospitals, clinics, and healthcare facilities that use albumin products. These factors, along with a generally aging population that requires more healthcare services, collectively serve to propel the market growth for the albumin industry in North America.

Competitive Landscape:

The global market is experiencing significant growth due to the new albumin formulations and applications. Innovation in this area can lead to more effective and versatile albumin products, opening new markets and therapeutic avenues. Along with this, companies are expanding into emerging markets where there is rising healthcare spending and an increasing patient pool. This diversification helps mitigate risks associated with dependence on mature markets. In addition, the escalating strategic partnerships with other healthcare companies, research institutions, and even governmental bodies help in sharing knowledge, costs, and distribution networks. Therefore, this is significantly supporting the market. With regulatory bodies emphasizing the safety and efficacy of medical products, companies in the albumin market are focusing on quality control to adhere to these guidelines, further impacting the market. In addition, brands are adopting advanced logistics and inventory management systems to ensure timely delivery, which is acting as another growth-inducing factor. Furthermore, product differentiation by offering albumin products that serve specific niches within healthcare is contributing to the market.

The market report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Albumedix Ltd.

Biotest AG

Celgene Corporation (Bristol-Myers Squibb Company)

CSL Limited

Grifols SA

HiMedia Laboratories

Medxbio Pte Ltd.

Merck KGaA

Octapharma AG

Takeda Pharmaceutical Company Limited

Thermo Fisher Scientific Inc.

Ventria Bioscience Inc.

Recent Developments:

In July 2023, Grifols SA finished enrolling participants in its Phase III PRECIOSA clinical study using long-term Albutein (albumin-human injectable) treatment to prolong life in patients with decompensated cirrhosis.

In June 2023, Albumedix Ltd announced the extension of its current partnership with Valneva SE, a specialized vaccination business devoted to the prevention of infectious illnesses with important unmet medical needs.

In October 2022, Biotest AG announced the signing of a Memorandum of Understanding with Biotest AG for the production of plasma derivatives under a private label by Alpha Pharma for the KSA market.

Key Questions Answered in This Report

  • 1. What was the size of the global albumin market in 2023?
  • 2. What is the expected growth rate of the global albumin market during 2024-2032?
  • 3. What are the key factors driving the global albumin market?
  • 4. What has been the impact of COVID-19 on the global albumin market?
  • 5. What is the breakup of the global albumin market based on the product?
  • 6. What is the breakup of the global albumin market based on the application?
  • 7. What is the breakup of the global albumin market based on end user?
  • 8. What are the key regions in the global albumin market?
  • 9. Who are the key players/companies in the global albumin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Albumin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Human Serum Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bovine Serum Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Recombinant Albumin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Formulation and Vaccine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Component of Media
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Albumedix Ltd
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Biotest AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Celgene Corporation (Bristol-Myers Squibb Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 CSL Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Grifols SA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 HiMedia Laboratories
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medxbio Pte Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Octapharma AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Ventria Bioscience Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Albumin Market: Major Drivers and Challenges
  • Figure 2: Global: Albumin Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Albumin Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Albumin Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Albumin Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Albumin Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Albumin Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Albumin (Human Serum Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Albumin (Human Serum Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Albumin (Bovine Serum Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Albumin (Bovine Serum Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Albumin (Recombinant Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Albumin (Recombinant Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Albumin (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Albumin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Albumin (Drug Formulation and Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Albumin (Drug Formulation and Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Albumin (Component of Media) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Albumin (Component of Media) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Albumin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Albumin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Albumin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Albumin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Albumin (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Albumin (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Albumin Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Albumin Industry: SWOT Analysis
  • Figure 78: Global: Albumin Industry: Value Chain Analysis
  • Figure 79: Global: Albumin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Albumin Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Albumin Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Albumin Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Albumin Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Albumin Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Albumin Market: Competitive Structure
  • Table 7: Global: Albumin Market: Key Players